SCHEMBL29332003

SCHEMBL29332003

Cc1cc(Br)cc2c1N(C)C(=O)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 7/20 0.47
BRD4 O60885 3/20 0.38
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
BMPR1B O00238 1/20 0.34
BMPR1A P36894 1/20 0.34
TGFBR1 P36897 1/20 0.34
ACVRL1 P37023 1/20 0.34
ACVR1 Q04771 1/20 0.34
SRD5A2 P31213 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
MAPT P10636 3/20 0.33
TP53 P04637 2/20 0.33
CYP17A1 P05093 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
MEN1 O00255 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22655285 0.86 BMPR1B (0.44) SRD5A1BRD4ALDH1A1GAABMPR1B
SCHEMBL14780019 0.81 SRD5A1 (0.46) SRD5A1BRD4SRD5A2NPSR1CYP17A1
SCHEMBL14779919 0.81 SRD5A1 (0.46) SRD5A1BRD4ALDH1A1BMPR1BBMPR1A
SCHEMBL8555796 0.79 BRD4 (0.38) SRD5A1BRD4BMPR1BBMPR1ATGFBR1
SCHEMBL18497031 0.72 POLB (0.52) BRD4ALDH1A1GAAMAPTTP53
SCHEMBL8555101 0.71 SRD5A1 (0.46) SRD5A1BRD4ALDH1A1MAPTCYP17A1
SCHEMBL265640 0.70 SRD5A1 (0.59) SRD5A1BRD4CYP17A1CYP1A2CYP19A1
SCHEMBL8556027 0.70 SRD5A1 (0.36) SRD5A1BRD4SRD5A2CYP17A1CYP1A2
SCHEMBL29209108 0.70 KMO (0.40) BRD4MAPTTP53CYP1A2CYP11B1
SCHEMBL10646148 0.69 SRD5A1 (0.36) SRD5A1NPSR1MAPTTP53CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228478-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 SRD5A1 506/4885BRD4 3282/4885ALDH1A1 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.